Comparison of Comet assay dose-response for ethyl methanesulfonate using freshly prepared versus cryopreserved tissues

Environmental and Molecular Mutagenesis

Volumn 53, Issue 2, 2012, Pages 101-113

  Recio, Leslie ^a   Kissling, Grace E ^b   Hobbs, Cheryl A ^a   Witt, Kristine L ^b  

^a ILS   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Comet assay; Cryopreservation; Ethyl methanesulfonate; Genotoxicity

Indexed keywords

DIMETHYL SULFOXIDE; LIQUID NITROGEN; MESYLIC ACID ETHYL ESTER;

ANIMAL EXPERIMENT; ARTICLE; BLOOD; COMET ASSAY; CONTROLLED STUDY; CRYOPRESERVATION; DNA DAMAGE; DOSE RESPONSE; FRESH TISSUE; FROZEN TISSUE; GENOTOXICITY; INTERMETHOD COMPARISON; LIVER; MALE; NONHUMAN; RAT; STOMACH; TISSUES;

ANIMALS; COMET ASSAY; CRYOPRESERVATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHYL METHANESULFONATE; LEUKOCYTES; LIVER; MALE; MUTAGENS; RATS; RATS, SPRAGUE-DAWLEY; STOMACH;

ANIMALIA; RATTUS;

EID: 84856573879     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.20694     Document Type: Article

References (39)

1. Bartsch, H. 1994. DNA Adducts: Identification and Biological Significance, IARC Scientific Publication No. 125. International Agency for Research on Cancer, Lyon, France.
2. Blakey D, Galloway SM, Kirkland DJ, MacGregor JT. 2008. Regulatory aspects of genotoxicity testing: From hazard identification to risk assessment. Mutat Res 657: 84-90.
3. Brendler-Schwaab S, Hartmann A, Pfuhler S, Speit G. 2005. The in vivo comet assay: Use and status in genotoxicity testing. Mutagenesis 20: 245-254.
4. Burlinson B, Tice RR, Speit G, Agurell E, Brendler-Schwaab SY, Collins AR, Escobar, P, Honma M, Kumaravel, TS, Nakajima M, Sasaki YF, Thybaud V, Uno Y, Vasquez M, Hartmann A. 2007. Fourth International Workgroup on Genotoxicity testing: Results of the in vivo Comet assay workgroup. Mutat Res 627: 31-35.
5. Clay P. 2008. Assessment of the genotoxicity of trichloroethylene and its metabolite, S-(1, 2-dichlorovinyl)-L-cysteine (DCVC), in the comet assay in rat kidney. Mutagenesis 23: 27-33.
6. Coffing S, Engel M, Dickinson D, Thiffeault C, Spellman R, Shutsky T, Schuler M. 2011. The rat gut micronucleus assay: A good choice for alternative in vivo genetic toxicology testing strategies. Environ Mol Mutagen 52: 269-279.
7. Collins AR, Oscoz AA, Brunborg G, Gaivao I, Giovannelli L, Kruszewski, Smith CC, Stetina R. 2008. The comet assay: Topical issues. Mutagenesis 23: 143-151.
8. Dearfield KL, Thybaud V, Cimino MC, Custer L, Czich A, Harvey JS, Hester S, Kim JH, Kirkland D, Levy DD, Lorge E, Moore MM, Ouédraogo-Arras G, Schuler M, Suter W, Sweder K, Tarlo K, van Benthem J, van Goethem F, Witt KL. 2011. Follow-up actions from positive results of in vitro genetic toxicity testing. Environ Mol Mutagen 52: 177-204.
9. Dipple A. 1995. DNA adducts of chemical carcinogens. Carcinogenesis 16: 437-441.
10. Eastmond DA, Hartwig A, Anderson D, Anwar WA, Cimino MC, Dobrev I, Douglas GR, Nohmi T, Phillips DH, Vickers C. 2009. Mutagenicity testing for chemical risk assessment: Update on the WHO/OPCS Harmonized Scheme. Mutagenesis 24: 341-349.
11. Fontini P, Raspaglio G, Falchi M, Dogliotti E. 1996. Analysis of DNA alkylation damage and repair in mammalian cells by the comet assay. Mutagenesis 11: 169-175.
12. Guyton KZ, Kyle AD, Aubrecht J, Cogliano VJ, Eastmond DA, Jackson M, Keshava N, Sandy MS, Sonawane B, Zhang L, Waters M, Smith MT. 2009. Improving prediction of chemical carcinogenicity by considering multiple mechanisms and applying toxicogenomic approaches. Mutat Res 681: 230-240.
13. Hartmann A, Agurell E, Beevers C, Brendler-Schwaab S, Burlinson B, Clay P, Collins A, Smith A, Speit G, Thybaud V, Tice RR. 2003. Recommendations for conducting in vivo alkaline Comet assay. 4th International Comet Workshop. Mutagenesis 18: 45-51.
14. Hartmann A, Schumacher M, Palppert-Helbig U, Lowe P, Suter W, Mueller L. 2004. Use of the alkaline in vivo Comet assay for mechanistic genotoxicity investigations. Mutagenesis 19: 51-59.
15. International Conference on Harmonisation of Technical Requirements for Registrations of Pharmaceuticals in Human Use (ICH). 1996. S2A: Guidance on Specific Aspects of Regulatory Genotoxicity Tests for Pharmaceuticals.
16. International Conference for Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). 1997. S2B: Genotoxicity: A Standard Battery for Genotoxicity Testing for Pharmaceuticals.
17. International Conference for Harmonistation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). 2008. S2(R1): Guidance on the Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use.
18. Japanese Center for the Validation of Alternative Methods (JaCVAM). 2009. International Validation of the in vivo rodent Alkaline Comet Assay for the Detection of Genotoxic Carcinogens Testing Protocol.
19. Jones GD, Le Pla RC, Farmer PB. 2010 Phosphotriester adducts (PTEs): DNA's overlooked lesion. Mutagenesis 25: 3-16.
20. Kendall M. 1938. A new measure of rank correlation. Biometrika 30: 81-89.
21. Kirkland DJ, Henderson L, Marzin D, Muller L, Parry JM, Speit G, Tweats DJ, Williams GM. 2005. Testing strategies in mutagenicity and genetic toxicology: An appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes. Mutat Res 588: 88-105.
22. Kirkland DJ, Speit G. 2008. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogents III. Appropriate follow-up testing in vivo. Mutat Res 654: 114-132.
23. Kumaravel TS, Jha AN. 2006. Reliable Comet assay measurements for detecting DNA damage induced by ionising radiation and chemicals. Mutat Res 605: 7-16.
24. Lambert IB, Singer TM, Boucher SE, Douglas GR. 2005. Detailed review of transgenic rodent mutation assays. Mutat Res 590: 1-280.
25. Lorge E, Gervais V, Becourt-Lhote N, Maisonneuve C, Delongeas JL, Claude N. 2007. Genetic toxicity assessment: employing the best science for human safety evaluation part IV: A strategy of genotoxicity testing in drug development: some examples. Toxicol Sci 98: 39-42.
26. Mann H, Whitney D. 1947. On a test of whether one of two random variables is stochastically larger than the other. Ann Mathematical Studies 18: 50-60.
27. Nesslany F, Zennouche N, Simar-Meintieres S, Talahari I, Nkili-Mboui EN, Marzin D. 2007. In vivo Comet assay on isolated kidney cells to distinguish genotoxic carcinogens from epigenetic carcinogens or cyotoxic compounds. Mutat Res 630: 28-41.
28. Oshida K, Iwanaga E, Miyamoto-Kuramitsu K, Miyamoto Y. 2008. An in vivo comet assay of multiple organs (liver, kidney and bone marrow) in mice treated with methyl methanesulfonate and acetaminophen accompanied by hematology and/or blood chemistry. J Toxicol Sci 33: 515-524.
29. Pfuhler S, Albertini S, Fautz R, Herbold B, Madle S, Utesch D, Poth A. 2007. Genetic toxicity assessment: Employing the best science for human safety evaluation part IV: Recommendation of a working group of the Gesellschaft fuer Umwelt-Mutationsforschung (GUM) for a simple and straightforward approach to genotoxicity testing. Toxicol Sci 97: 237-240.
30. Recio L, Hobbs C, Caspary W, Witt KL. 2010. Dose-response assessment of four genotoxic chemicals in a combined mouse and rat micronucleus (MN) and comet assay protocol. J Toxicol Sci 35: 149-162.
31. Rothfuss A, Honma M, Czich A., Aardema MJ, Burlinson B, Galloway, S, Hamada S, Kirkland D, Heflich RH, Howe J, Nakajima M, O'Donovan M, Plappert-Helbig U, Priestley C, Recio L, Schuler M, Uno Y, Martus, HJ. 2011. Improvement of in vivo genotoxicity assessment: Combination of acute tests and integration into standard toxicity testing. Mutat Res 723: 108-120.
32. Sasaki YF, Sekihasi K, Izumiyama F, Nishidate E, Saga A, Ishida K, Tsuda S. 2000. The comet assay with multiple mouse organs: Comparison of commet assay results and carcinogenicity with 208 chemicals selected from the IARC monographs and U.S. NTP Carcinogencity Database. Crit Rev Toxicol 30: 629-799.
33. Sega GA. 1984 A review of the genetic effects of ethyl methanesulfonate. Mutat Res 134: 113-142.
34. Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, Miyamae Y, Rojas E, Ryu JC, Sasaki YK. 2000. Single cell gel/comet assay: Guidelines for in vitro genetic toxicology testing. Environ Mol Mutagen 35: 206-221.
35. White I, Plappert U, deWall H, Hartmann A. 2007. Genetic toxicity assessment employing the best science for human safety evaluation part III: The comet assay as an alternative to in vitro clastogenicity tests for early drug candidate selection. Toxicol Sci 97: 21-26.
36. Williams DA. 1971. A test for differences between treatment means when several dose levels are compared with a zero dose control. Biometrics 27: 103-117.
37. Williams DA. 1972. The comparison of several dose levels with a zero dose control. Biometrics 28: 519-531.
38. Witt KL, Livanos E, Kissling GE, Torous DK, Caspary W, Tice RR, Recio L. 2008. Comparison of flow cytometry and microscopy-based methods for measuring micronucleated reticulocyte frequencies in rodents treated with nongenotoxic and genotoxic chemicals. Mutat Res 649: 101-113.
39. Witt KL, Malarkey DE, Hobbs CA, Davis JP, Kissling GE, Caspary W, Travelos G, Recio L. 2010. No increases in biomarkers of genetic damage or pathological changes in heart and brain tissues in male rats administered methylphenidate hydrochloride (Ritalin) for 28 days. Environ Mol Mutagen 51: 80-88.